VX-710
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VX-710, covering 2013-09-05 to 2013-09-05. Get the full timeline:
Most recent: Clinical Trial Update: VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer [Phase 2]